LEADER 02682nas  2200409   450 
001 996211918003316
005 20240221132210.0
011   $a1930-4315
035   $a(CKB)1000000000240273
035   $a(DE-599)ZDB2492635-8
035   $a(NjHacI)991000000000240273
035   $a(EXLCZ)991000000000240273
100   $a20240221a20079999  uy              
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aScience & practice perspectives /$fNational Institute on Drug Abuse
210  1$aBethesda, MD :$cNational Institute on Drug Abuse,$d2007.
215   $a1 online resource
311   $a1930-4307 
327   $aA Note From NIDA's Director--Two Perspectives, One Goal--Editor's Note--Dialogue and Collaboration: A Path for Progress--Research Review--HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research--Response: Applying HIV Strategies to Hepatitis Prevention--The Neurobiology of Opioid Dependence: Implications for Treatment--Thomas R. Kosten, Tony P. George--Response: The Neurobiological Model in Community Treatment Programs--Tom Brewster, Chris Farentinos, Douglas Ziedonis--Clinical Perspectives--Treatment Practice and Research Issues in Improving Opioid Treatment Outcomes--T. Ron Jackson--Response: The New Environment of Accountability for OTPs--R. Lorraine Collins, William Cornely, Christine Grella--Treating Women Drug Abusers: Action Therapy and Trauma Assessment--Ann S. Uhler, Olga V. Parker--Response: Treating Women on their own Terms--R. Lorraine Collins, William Cornely, Christine Grella--Science and Practice in Action--Using Behavioral Reinforcement To Improve Methadone Treatment Participation--Robert K. Brooner, Michael Kidorf--Response : Implementing Motivational Stepped Care--Tom Brewster, Chris Farentinos, Douglas Ziedonis--Connecticut Partnership Targets Substance-Abusing Parents--Kathleen Carroll, Bryce Libby, Joseph Sheehan, Debbie Beckwith, Nancy C. Hyland, Sue Caulkins--Departments--This Issue's Authors & Panel Respondents--Graphic Evidence--The Consequences of Long-Term Heroin Addiction and the Effects of Treatment.
531   $aSCI PRACT PERSPECT
531   $aSCIENCE AND PRACTICE PERSPECTIVES
606   $aHealth Sciences$xClinical Medicine
606   $aSubstance abuse$vTreatment
615  4$aHealth Sciences$xClinical Medicine.
615  0$aSubstance abuse
676   $a362.29
712 02$aMasiMax Resources, Inc,
801  0$bNjHacI
801  1$bNjHacl
906   $aJOURNAL
912   $a996211918003316
996   $aScience & practice perspectives$93911449
997   $aUNISA